Fixed-Dose HIV Combo Therapy tentatively approved by FDA
February 21st 2018Officials with the FDA have granted tentative approval to dolutegravir, emtricitabine, and tenofovir alafenamide(DTG/FTC/TAF) tablets, 50-mg/200-mg/25-mg, under the US President’s Emergency Plan for AIDS Relief (PEPFAR) program.